Axalta/AkzoNobel Merger Presentation Names Combined Company 'Axanzo' (NYSE: AXZ)
AXTA sits 35% above its 52-week low of $24.937.
Summary
Axalta's latest merger presentation reveals the combined company would be named Axanzo (NYSE: AXZ), sizes the North America Building Products divestiture at about $600M, and puts merger remedies at 100-200 bps.
Key Events · M&A and Partnerships · AXTA
-
Combined Company Named Axanzo
The investor presentation introduces 'Axanzo' as the new name for the combined AkzoNobel-Axalta company, with an intended NYSE ticker of AXZ.
-
Divestiture Sized at ~$600M
Axalta's North America Building Products business, being divested to satisfy merger regulators, is sized at approximately $600M in the presentation.
-
Remedies at 100-200 bps
Merger remedies are quantified at 100-200 bps, following the October 21 disclosure that remedies cover just under EUR500 million of combined revenue.
-
Approvals and Closing Pending
Shareholders approved the transaction on August 5, 2026; the presentation shows regulatory clearance as the remaining milestone before closing.
Analysis · AXTA · Industrial Applications And Services
This Rule 425 filing is an investor-presentation excerpt for the pending all-share merger of equals between Axalta and AkzoNobel. What's new is branding and remedy sizing: the combined company would be called Axanzo and trade on the NYSE under AXZ, Axalta's North America Building Products divestiture is sized at roughly $600M, and merger remedies are put at 100-200 bps. Shareholders already approved the deal on August 5, 2026, and EU clearance was expected with conditions, so the remaining variable is regulatory sign-off and closing rather than deal terms.
How filings like this one have moved
In the 30 days to Oct 29, 2026, 30.9% of the 1649 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.02%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AXTA was trading at $33.61 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $7.2B. The 52-week trading range was $24.94 to $38.61. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.